Bates, David W. http://orcid.org/0000-0001-6268-1540
Levine, David
Syrowatka, Ania http://orcid.org/0000-0002-7161-9770
Kuznetsova, Masha
Craig, Kelly Jean Thomas http://orcid.org/0000-0002-9954-2795
Rui, Angela
Jackson, Gretchen Purcell http://orcid.org/0000-0002-3242-8058
Rhee, Kyu
Funding for this research was provided by:
IBM Watson
Article History
Received: 27 April 2020
Accepted: 16 February 2021
First Online: 19 March 2021
Competing interests
: Dr. Bates consults for EarlySense, which makes patient safety monitoring systems. He receives cash compensation from CDI (Negev), Ltd, which is a not-for-profit incubator for health IT startups. He receives equity from ValeraHealth, which makes software to help patients with chronic diseases. He receives equity from Clew, which makes software to support clinical decision-making in intensive care. He receives equity from MDClone, which takes clinical data and produces deidentified versions of it. He receives equity from AESOP, which makes software to reduce medication error rates. Drs. Craig, Jackson, and Rhee are all employed by IBM Watson Health. The other coauthors have no disclosures.